Company AntriaBio Inc OTC Bulletin Board
Equities
US0372301095
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 17 | Transcript : Rezolute, Inc. - Shareholder/Analyst Call | |
Apr. 18 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 10-07-25 | |
Nevan Elam
CEO | Chief Executive Officer | 56 | 10-07-25 |
Daron Evans
DFI | Director of Finance/CFO | 50 | Jan. 23 |
Chief Tech/Sci/R&D Officer | - | 21-05-19 | |
Brain Roberts
CTO | Chief Tech/Sci/R&D Officer | 49 | 16-12-31 |
Chris Milks
PRN | Corporate Officer/Principal | - | - |
Erin O’Boyle
PRN | Corporate Officer/Principal | - | 19-02-28 |
Michael Deperro
PRN | Corporate Officer/Principal | - | 15-12-31 |
Susan Stewart
LAW | General Counsel | 64 | 21-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nevan Elam
CEO | Chief Executive Officer | 56 | 10-07-25 |
Young-Jin Kim
BRD | Director/Board Member | 67 | 19-02-09 |
Gil Labrucherie
BRD | Director/Board Member | 52 | 19-11-19 |
Philippe Fauchet
BRD | Director/Board Member | 65 | 20-09-09 |
Nerissa Kreher
BRD | Director/Board Member | 51 | 21-03-01 |
Director/Board Member | 59 | 21-03-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,135,147 | 31,953,951 ( 79.62 %) | 0 | 79.62 % |
Company contact information
Rezolute, Inc.
275 Shoreline Drive Suite 500
94065, Redwood City
+650 206 4507
http://www.rezolutebio.comSector
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- RZLT Stock
- Stock
- Company AntriaBio Inc